OncoZenge: Partnership with UCLA - Redeye

Redeye leaves a comment following OncoZenge’s announcement of a collaboration with UCLA, marking an important first step toward a potential future US market entry for BupiZenge. We view this initiative as a strategically sound move that broadens the scope of the program beyond Europe, while also providing valuable patient insights to support future regulatory and clinical planning in the US.

Länk till analysen i sin helhet: https://www.redeye.se/research/1128179/oncozenge-partnership-with-ucla?utm_source=finwire&utm_medium=RSS